| DETERMINATION OF HUMAN ABSORBED DOSE OF 201Tl(III)-DTPA-HIgG BASED ON BIODISTRIBUTION DATA IN RATS VHSS Alireza Khorrami Moghaddam1,*, Amir Reza Jalilian2 Radiation Protection Dosimetry, 2010 | 16 | 2010 |
| Preparation, quality control and biodistribution studies of [67Ga]-DOTA-anti-CD20 AR Jalilian, L Mirsadeghi, R Haji-Hosseini, A Khorrami Radiochimica Acta 96 (3), 167-174, 2008 | 13 | 2008 |
| Preparation and quality control and biodistribution studies of [90 Y]-DOTA-cetuximab for radioimmunotherapy A Vakili, AR Jalilian, K Yavari, S Shirvani-Arani, A Khanchi, ... Journal of Radioanalytical and Nuclear Chemistry 296 (3), 1287-1294, 2013 | 10 | 2013 |
| Production and quality control of [166Ho]-DOTA-bevacizumab for therapeutic applications MGM herape Alireza Khorami-Moghadam, Amir Reza Jalilian, Kamal Yavari ... Radio analytical and nuclear chemistry 292 (3), 1065-1073, 2012 | 9* | 2012 |
| Development of [201Tl](III)-DTPA-human polyclonal antibody complex for inflammation detection AR Jalilian, A Khorrami, MB Tavakoli, M Kamali-Dehghan, YY Kamrani Radiochimica Acta 95 (11), 669-675, 2007 | 8 | 2007 |
| Evaluation And Calculation of Human absorbed dose of (201) Tl (III)-DTPA-HIgG based on biodistribution data in rats AK Moghaddam, AR Jalilian, V Hayati, S Shanehsazzadeh, A Dodangeh Journal of Labelled Compounds & Radiopharmaceuticals 54, S347-S347, 2011 | 7 | 2011 |
| Detecting adhd children using the attention continuity as nonlinear feature of eeg A Allahverdy, AK Moghadam, MR Mohammadi, AM Nasrabadi Frontiers in Biomedical Technologies 3 (1-2), 28-33, 2016 | 6 | 2016 |
| Preclinical evaluation of holmium-166 labeled anti-VEGF-A(Bevacizumab) SMMBA Alireza Khorami-Moghadam1, Bahram Bolouri1,*, Amir Reza Jalilian2 ... Journal of Labelled Compounds and Radiopharmaceuticals 56 (8), 365–369, 2013 | 5 | 2013 |
| Preclinical pharmacokinetic, biodistribution, radiation dosimetry, and toxicity studies of 99mTc-HYNIC-(Ser) 3-LTVPWY: a novel HER2-targeted peptide radiotracer JB Ardakani, FT Amiri, A Khorramimoghaddam, A Abbasi, ... Regulatory Toxicology and Pharmacology 112, 104591, 2020 | 2 | 2020 |
| An agent-based model for investigating the effect of myeloid-derived suppressor cells and its depletion on tumor immune surveillance A Allahverdy, AK Moghaddam, S Rahbar, S Shafiekhani, HR Mirzaie, ... Journal of medical signals and sensors 9 (1), 15, 2019 | 2 | 2019 |
| Synthesis, radiolabeling and quality control of 111In-DOTA-bevacizumab for radioimmunoscintigraphy of VEGF receptors AKMARJKYBAMMM Mirzaii1 Radiochimica Acta 101 (9), 577–584, 2013 | 2 | 2013 |
| Compartmental Analysis to Predict the Biodistribution of [166Ho]-DOTA-Bevacizumab for Targeted Radiotherapy Purpose AK Moghaddam, A Hakimi, A Mardanshahi, AR Jalilian, H Amirfakhrian, ... Frontiers in Biomedical Technologies 2 (3), 118-127, 2015 | 1 | 2015 |
| Radiolabeling Quality Control and Biodistribution Study of Anti-CD20 Antibody by 67 Ga AR Jalilian, L Mirsadeghi, A Khorrami, S Moradkhani, B Naseriyan, ... Journal of Nuclear Science and Technology, 10-17, 2009 | 1 | 2009 |
| Preparation and evaluation of [201Tl](III)-DTPA-HIgG for inflammation detection AR Jalilian, DM KAMALI, YY KAMRANI, A KHORRAMI, MB TAVAKOLI, ... INTERNATIONAL JOURNAL OF RADIATION RESEARCH 4 (3), 105-114, 2006 | 1 | 2006 |
| Gamma Spectrometry in the Presence of Fast Neutrons A Allahverdy, O Jahanbakhsh, AK Moghaddam Frontiers in Biomedical Technologies 6 (1), 22-27, 2019 | | 2019 |
| Differentiating Tumor and Edema in Brain Magnetic Resonance Images Using a Convolutional Neural Network A Allahverdi, S Akbarzadeh, AK Moghaddam, A Allahverdy Frontiers in Biomedical Technologies 5 (1-2), 44-50, 2018 | | 2018 |
| Determination of gamma-ray shielding properties for silicate glasses containing Bi2O3, PbO, and BaO MS Reza Bagheri a, Alireza Khorrami Moghaddam b, Seyed Pezhman Shirmardi c ... 13 October 2017, 2017 | | 2017 |
| Optimization of Image Quality and Patient Dose in Digital Radiography of the Chest R Paydar, SH Mousavie Anijdan, A Khorrami Moghaddam, I Mohammadi, ... Journal of Babol University of Medical Sciences 19 (7), 57-62, 2017 | | 2017 |
| Development of Sm-153-DOTA-Bevacizumab for radiotargeted therapy in rat model AK Moghaddam, A Mardanshahi, SM Abedi, A Jalilian JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS 60, S342-S342, 2017 | | 2017 |
| Gamma-ray shielding study of light to heavyweight concretes using MCNP-4C code RBAKMA Yousefi1 NUCLEAR SCIENCES TECHNOLOGY, 2017 | | 2017 |
Amirreza JalilianRadioisotope and Radiopharmaceutical ChemistVerified email at iaea.org
